Technology for Diagnosis and Treatment
The functional integration of man-made devices and biological systems represents one of the grand challenges of science and technology and it is now widely accepted that a combination of medical engineering and nanotechnology that harnesses the full potential of proteomic and genomic information through real-time, predictive, preventive, point-of-care healthcare provision will lead to the next technological revolution.
The work of Diagnostic & Therapeutic Technologies in Sensor Systems & Nanomedicine lies at the heart of modern medical engineering and care provision by working at the interface between nano-, bio-, micro- and genomic engineering technologies to develop new systems and device technologies and by applying these new technologies in areas of real medical need in order to improve patient care and management.
Spanning prevention, diagnosis, treatment and after-care, Cardiovascular Physics & Engineering research is wide-ranging but focuses on major health concerns such as cardiovascular disease, one of the main causes of mortality and morbidity both locally and nationally. The group’s commitment to translational research is exemplified by the ongoing development of new screening methods for cardiac arrhythmias, such as atrial fibrillation which is highly prevalent in the elderly and a major cause of stroke. Additionally, the group is researching improved methods of blood pressure measurement to improve the accuracy of automated devices for self-monitoring.
These developments are undertaken in partnership with clinicians at the Newcastle Hospitals NHS Foundation Trust, with biomedical engineering groups around the world and with the UK medical devices industry.
If you are interested in finding out more about the work of Diagnostic & Therapeutic Technologies you are encouraged to contact either Prof Calum McNeil or Dr Philip Langley.
